1
|
ElFessi-Magouri R, Peigneur S, Khamessi O, Srairi-Abid N, ElAyeb M, Mille BG, Cuypers E, Tytgat J, Kharrat R. Kbot55, purified from Buthus occitanus tunetanus venom, represents the first member of a novel α-KTx subfamily. Peptides 2016; 80:4-8. [PMID: 26079392 DOI: 10.1016/j.peptides.2015.05.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2015] [Revised: 05/26/2015] [Accepted: 05/28/2015] [Indexed: 01/13/2023]
Abstract
Kbot55 is a 39 amino acid peptide isolated from the venom of the Tunisian scorpion Buthus occitanus tunetanus. This peptide is cross-linked by 3 disulfide bridges and has a molecular mass of 4128.65Da. Kbot55 is very low represented in the venom and thus represents a challenge for biochemical characterization. In this study, Kbot55 has been subjected to a screening on ion channels expressed in Xenopus laevis oocytes. It was found that Kbot55 targets voltage-gated potassium channels with high affinity. Kbot55 shows very low amino acid identity with other scorpion potassium toxins and therefore was considered a bona fide novel type of scorpion toxin. Sequence alignment analysis indicated that Kbot55 is the first representative of the new α-Ktx31 subfamily and therefore was classified as α-Ktx31.1.
Collapse
Affiliation(s)
- Rym ElFessi-Magouri
- Laboratoire des Venins et Molécules Thérapeutiques, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia
| | - Steve Peigneur
- Toxicology & Pharmacology, University of Leuven (K.U. Leuven), Campus Gasthuisberg O&N2, Herestraat 49, P.O. Box 922, B-3000 Leuven, Belgium
| | - Oussema Khamessi
- Laboratoire des Venins et Molécules Thérapeutiques, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia
| | - Najet Srairi-Abid
- Laboratoire des Venins et Molécules Thérapeutiques, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia
| | - Mohamed ElAyeb
- Laboratoire des Venins et Molécules Thérapeutiques, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia
| | - Bea Garcia Mille
- Toxicology & Pharmacology, University of Leuven (K.U. Leuven), Campus Gasthuisberg O&N2, Herestraat 49, P.O. Box 922, B-3000 Leuven, Belgium
| | - Eva Cuypers
- Toxicology & Pharmacology, University of Leuven (K.U. Leuven), Campus Gasthuisberg O&N2, Herestraat 49, P.O. Box 922, B-3000 Leuven, Belgium
| | - Jan Tytgat
- Toxicology & Pharmacology, University of Leuven (K.U. Leuven), Campus Gasthuisberg O&N2, Herestraat 49, P.O. Box 922, B-3000 Leuven, Belgium
| | - Riadh Kharrat
- Laboratoire des Venins et Molécules Thérapeutiques, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis, Tunisia.
| |
Collapse
|